President and COO ResMed Inc. of Resmed Inc (30-Year Financial, Insider Trades) Robert Andrew Douglas (insider trades) sold 4,111 shares of RMD on 07/15/2019 at an average price of $124.5 a share. The total sale was $511,820.
ResMed Inc is a part of the healthcare sector. It develops and distributes medical products for treating and diagnosing respiratory disorders. ResMed Inc has a market cap of $17.78 billion; its shares were traded at around $123.97 with a P/E ratio of 40.26 and P/S ratio of 7.08. The dividend yield of ResMed Inc stocks is 1.20%. ResMed Inc had annual average EBITDA growth of 12.40% over the past ten years. GuruFocus rated ResMed Inc the business predictability rank of 3.5-star. GuruFocus has detected 3 severe warning signs with ResMed Inc. .
CEO Recent Trades:
- CEO Michael J. Farrell sold 6,651 shares of RMD stock on 07/08/2019 at the average price of $123.76. The price of the stock has increased by 0.17% since.
CFO Recent Trades:
- CFO Brett Sandercock sold 3,000 shares of RMD stock on 07/01/2019 at the average price of $123.17. The price of the stock has increased by 0.65% since.
Directors and Officers Recent Trades:
- President and COO ResMed Inc. Robert Andrew Douglas sold 4,111 shares of RMD stock on 07/15/2019 at the average price of $124.5. The price of the stock has decreased by 0.43% since.
- Chief Administrative Officer David Pendarvis sold 4,367 shares of RMD stock on 07/03/2019 at the average price of $123.86. The price of the stock has increased by 0.09% since.
- President, Sleep Business James Hollingshead sold 1,600 shares of RMD stock on 07/01/2019 at the average price of $123.17. The price of the stock has increased by 0.65% since.
For the complete insider trading history of RMD, click here
.
